VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,922 | +78.7% | 1,372 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $20,656 | -27.8% | 686 | -22.4% | 0.00% | -50.0% |
| Q1 2023 | $28,598 | +12.9% | 884 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,335 | +20.6% | 884 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,000 | -12.5% | 884 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -54.7% | 884 | -36.1% | 0.00% | -50.0% |
| Q1 2022 | $53,000 | -17.2% | 1,384 | -30.7% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | +12.3% | 1,998 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -33.7% | 1,918 | -23.8% | 0.00% | -42.9% |
| Q2 2021 | $86,000 | +7.5% | 2,518 | +2.4% | 0.01% | 0.0% |
| Q1 2021 | $80,000 | -10.1% | 2,458 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $89,000 | +21.9% | 2,458 | +32.3% | 0.01% | 0.0% |
| Q3 2020 | $73,000 | +942.9% | 1,858 | +838.4% | 0.01% | +700.0% |
| Q2 2020 | $7,000 | +40.0% | 198 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |